Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series #MMPMID32389697
Dogan L; Kaya D; Sarikaya T; Zengin R; Dincer A; Akinci IO; Afsar N
Brain Behav Immun 2020[Jul]; 87 (?): 155-158 PMID32389697show ga
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).